Group 1 - On November 17, Jianfa Zhixin's stock price dropped by 3.44%, with a trading volume of 481 million yuan [1] - The financing data shows that on the same day, Jianfa Zhixin had a financing purchase amount of 43.37 million yuan and a financing repayment of 49.50 million yuan, resulting in a net financing outflow of 6.13 million yuan [1] - As of November 17, the total balance of margin trading for Jianfa Zhixin was 131 million yuan, accounting for 7.50% of its circulating market value [1] Group 2 - As of September 30, Jianfa Zhixin had 38,000 shareholders, an increase of 151.60% compared to the previous period, while the average circulating shares per person decreased by 60.25% to 1,327 shares [2] - For the period from January to September 2025, Jianfa Zhixin achieved an operating income of 14.861 billion yuan, representing a year-on-year growth of 10.18%, and a net profit attributable to shareholders of 230 million yuan, which is a year-on-year increase of 45.01% [2] Group 3 - Jianfa Zhixin, established on August 30, 2010, is located at 288 Yangshupu Road, Yangpu District, Shanghai, and is primarily engaged in the direct sales and distribution of medical devices, as well as providing centralized operation services for medical consumables to terminal hospitals [1] - The main revenue composition of Jianfa Zhixin includes: vascular intervention (55.61%), surgical instruments (21.46%), in vitro diagnostic reagents (13.05%), medical equipment (6.24%), other medical devices (2.79%), SPD and other services (0.63%), and others (0.23%) [1]
建发致新11月17日获融资买入4337.41万元，融资余额1.31亿元